Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese

MALVERN, Pa., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news